Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer.

A new interesting article has been published in Invest New Drugs. 2019 May 23. doi: 10.1007/s10637-019-00785-5. and titled: Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of…

Continue Reading Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer.

Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Can…

A new interesting article has been published in Mar Drugs. 2019 May 24;17(5). pii: E305. doi: 10.3390/md17050305. and titled: Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition…

Continue Reading Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Can…

CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.

A new interesting article has been published in Thorac Cancer. 2019 May 23. doi: 10.1111/1759-7714.13097. and titled: CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation…

Continue Reading CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.

Comparative proteomic analysis to characterize temperature-induced viable but non-culturable and resuscitation states in Vibrio cholerae.

A new interesting article has been published in Microbiology. 2019 May 24. doi: 10.1099/mic.0.000798. and titled: Comparative proteomic analysis to characterize temperature-induced viable but non-culturable and resuscitation states in Vibrio…

Continue Reading Comparative proteomic analysis to characterize temperature-induced viable but non-culturable and resuscitation states in Vibrio cholerae.

Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblast…

A new interesting article has been published in Inflammopharmacology. 2019 May 23. doi: 10.1007/s10787-019-00605-5. and titled: Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3…

Continue Reading Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblast…